Studies have demonstrated that severe proteinuria (Chen et al., 2019), reduced baseline eGFR (Zuo et al., 2013), age ≥ 60 years, low serum albumin concentrations, and severe tubulointerstitial damage (Yin et al., 2020) are associated with poor renal prognosis in aMN. Here, ALB is linked to adrenomyeloneuropathy.